At its ThoughtSpot 2015 conference, which ended this weekend, AmerisourceBergen Corp. introduced a range of new capabilities for its Pharmacy Services Administration Organization that will bolster support of its Good Neighbor Pharmacy independent pharmacy network.
Hikma Pharmaceuticals PLC, a fast growing multinational pharmaceutical group, plans to acquire Roxane Laboratories from Boehringer Ingelheim in a deal valued at $2.65 billion. Hikma said the agreement stands to transform its position in the U.S.
CVS Health has formed new clinical affiliations with Lawrence Memorial Hospital in Kansas and Lehigh Valley Health Network in Pennsylvania.
Par Pharmaceutical Companies Inc. has released an authorized generic version of Par Specialty Pharmaceutical’s Megace ES oral suspension.
Comparable pharmacy sales growth more than offset flat front-end results to lift Rite Aid Corp.’s same-store sales for July. Rite Aid said Thursday that for the four weeks ended July 25, comparable-store sales rose 2.4% year over year, matching the comp-store growth posted in June.
CVS Health and IBM are pooling their expertise in predictive analytics and leveraging the information technology giant’s Watson cognitive computing platform to improve care management for patients with chronic diseases.
The Jean Coutu Group is prepping patients and pharmacists for expanded health care services now available through pharmacies in Quebec.
Unilever and Walgreens have partnered with Me to We to provide customers with a way to make a positive impact on the world through everyday purchases.
Reliance ACO, an accountable care organization in southeastern Michigan, has joined the Rite Aid Health Alliance team-based care initiative. Rite Aid Corp. said Wednesday that Reliance ACO is the eighth health provider partner in the Rite Aid Health Alliance, announced in March 2014.
Troy Healthcare is expanding retail distribution of its Stopain Migraine topical pain reliever, which a recent study found to be safe and effective in treating an acute migraine attack.
David Taylor, Procter & Gamble Co.’s group president of global beauty, grooming and health care, has been chosen to succeed A.G. Lafley as the company’s president and chief executive officer. P&G said late Tuesday that Taylor is slated to take the helm as CEO on Nov.
A new sonic toothbrush from Brush Buddies brings consumers a “fresh-out-of-the-dentist clean feeling at drug store prices,” the company said.
An initiative by Shoppers Drug Mart, the Canadian government and the Canadian Coalition for Seniors’ Mental Health (CCSMH) aims to help seniors grappling with depression and thoughts of suicide.
Sandoz has launched budesonide inhalation suspension, an asthma medication, in the U.S. market. The Novartis subsidiary said Tuesday that it will market its budesonide inhalation suspension in 1-mg strength, and it expects 180-day generic drug marketing exclusivity for that dosage.
Teva Pharmaceutical Industries Ltd. plans to buy Allergan’s generic drug business for about $40.5 billion and, with the deal, has withdrawn its proposal to acquire Mylan N.V. for approximately $40 billion. Teva said Monday that Dublin, Ireland-based Allergan will receive $33.
Exhibit space for the 2015 NACDS Total Store Expo has sold out, a month before the annual chain drug industry event kicks off in Denver.
